Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Ritz

Showing results (261-270 of 315) with videos related to

Pageof 32
Sort By:
Cancer Discovery|April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung CancerDennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Nature Biotechnology|October 4, 2024
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responsesShaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.
Blood|April 9, 2015
Targeting Syk-activated B cells in murine and human chronic graft-versus-host diseaseRyan Flynn, Jessica L Allen, Leo Luznik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Blood|November 8, 2019
Inhibition of inositol kinase B controls acute and chronic graft-versus-host diseaseGovindarajan Thangavelu, Jing Du, Katelyn G Paz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisRuxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, et al.
JCI Insight|June 15, 2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibitionEdouard Forcade, Katelyn Paz, Ryan Flynn, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Pageof 32

Showing results (261-270 of 315) with videos related to

Sort By:
Pageof 32
Cancer Discovery|April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung CancerDennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
Blood|May 14, 2014
Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransRyan Flynn, Jing Du, Rachelle G Veenstra, et al.
Nature Biotechnology|October 4, 2024
Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responsesShaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.
Blood|April 9, 2015
Targeting Syk-activated B cells in murine and human chronic graft-versus-host diseaseRyan Flynn, Jessica L Allen, Leo Luznik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Blood|November 8, 2019
Inhibition of inositol kinase B controls acute and chronic graft-versus-host diseaseGovindarajan Thangavelu, Jing Du, Katelyn G Paz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2024
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisRuxandra F Sîrbulescu, Katharine Nicholson, Kento Kawai, et al.
JCI Insight|June 15, 2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibitionEdouard Forcade, Katelyn Paz, Ryan Flynn, et al.
The Journal of Clinical Investigation|September 30, 2025
Acetyl-CoA carboxylase 1 inhibition increases Treg metabolism and graft-versus-host disease treatment efficacy via mitochondrial fusionCameron McDonald-Hyman, Ethan G Aguilar, Ewoud B Compeer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Pageof 32